M. Albers

Phenex Pharmaceuticals (Germany)

Papers

1

Total Citations

124

H-Index

1

About

Dr. M. Albers is a molecular biologist whose work has significantly advanced the high-throughput analysis of protein-protein interactions, particularly within the nuclear receptor signaling network. Their most impactful contribution, the 2004 paper "Automated Yeast Two-hybrid Screening for Nuclear Receptor-interacting Proteins," has garnered 124 citations, establishing it as a cornerstone in hypothesis-generating interactomics. In this landmark study, Albers developed and validated an automated, improved version of the classic yeast two-hybrid system, enabling a large-scale screening project that systematically mapped interactions between nuclear receptors and their cofactors. This methodological innovation not only accelerated the discovery of novel binding partners but also provided a robust, reproducible platform for the broader research community. By streamlining a traditionally labor-intensive technique, Albers’ work has empowered subsequent studies in gene regulation and endocrine biology, offering a powerful tool for dissecting complex cellular networks. Their contributions remain essential reading for researchers exploring the molecular underpinnings of nuclear receptor function and the dynamic landscape of protein interaction mapping.

Research Focus

Key Achievements

1
H-Index
1
Papers
124
Total Citations
124
Avg Citations/Paper
🏆 Most Cited Paper
Automated Yeast Two-hybrid Screening for Nuclear Receptor-interacting Proteins
124 citations · 2004
📈 Most Prolific Year: 2004 (1 Papers)
🤝 Key Collaborators: 7
🏛 Institutions: Phenex Pharmaceuticals (Germany)

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago